Health News: [diabetes ]: Doctors make progress toward 'artificial pancreas'

Yahoo! Health   |  My alerts   |   Edit Alert Saturday, Jun 22, 2013 12:11 PM EDT

Health News : diabetes - Top images.

Health News : diabetes - News from other sources.   Doctors make progress toward 'artificial pancreas' Sat, 22 Jun, 2013 09:02 AM PDT Doctors are reporting a major step toward an 'artificial pancreas,' a device that would constantly monitor blood sugar in people with diabetes and automatically supply insulin as needed. Continue reading BUSINESS WIRE: Study finds investigational compound empagliflozin reduced blood glucose in adults with Type 2 Diabetes ... Sat, 22 Jun, 2013 08:49 AM PDT MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.Data presented at American Diabetes Association 73rd Scientific Sessions® also showed reductions in weight and blood pressureINGELHEIM, Germany & INDIANAPOLIS, US --(BUSINESS WIRE)-- 22.06.2... Continue reading BUSINESS WIRE: Trajenta® (linagliptin): New data on safety and efficacy in Type 2 Diabetes patients with moderate to ... Sat, 22 Jun, 2013 08:49 AM PDT MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.Data presented at the American Diabetes Association (ADA) 73rd Scientific Sessions® provides insights for use of Trajenta® (linagliptin) in adults with Type 2 Diabetes (T2D) with mode... Continue reading BUSINESS WIRE: New efficacy and safety data presented for Trajenta® (linagliptin) in Asians with Type 2 Diabetes Sat, 22 Jun, 2013 08:49 AM PDT MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.New Phase III data presented at the American Diabetes Association 73rd Scientific Sessions® (ADA) showed linagliptin improved blood glucose control as monotherapy and in combination with met... Continue reading BUSINESS WIRE: Phase III data show investigational compound empagliflozin reduced blood glucose in adults with Type 2 ... Sat, 22 Jun, 2013 08:49 AM PDT MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.Data presented at the American Diabetes Association 73rd Scientific Sessions® also showed reduction in required insulin dose in treated study subjectsINGELHEIM, Germany & Indianapolis, US --... Continue reading BUSINESS WIRE: Phase III data show significant reduction in blood glucose with investigational compound empagliflozin ... Sat, 22 Jun, 2013 08:48 AM PDT MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.Data presented at the American Diabetes Association 73rd Scientific Sessions® also showed statistically significant reductions in mean daily glucose and body weight in treated study subjects... Continue reading BUSINESS WIRE: Phase III data show significant reductions in blood glucose with investigational compound empagliflozin ... Sat, 22 Jun, 2013 08:48 AM PDT MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.Data presented at the American Diabetes Association 73rd Scientific Sessions® also showed reduction in body weight and systolic blood pressure in treated study subjectsFor Non-US and Non-UK ... Continue reading Doctors make progress toward 'artificial pancreas' for diabetics Sat, 22 Jun, 2013 08:44 AM PDT Doctors are reporting a major step toward an "artificial pancreas," a device that would constantly monitor blood sugar in people with diabetes and automatically supply insulin as needed. Continue reading New analysis shows that patients with Type 2 diabetes and mild renal impairment had similar improvement in blood sugar ... Sat, 22 Jun, 2013 08:40 AM PDT ( GCI Health NY ) Merck, known as MSD outside the United States and Canada, today announced results from a post-hoc pooled analysis showing patients with Type 2 diabetes and mild renal impairment treated with JANUVIA (sitagliptin) 100 mg once-daily achieved similar blood sugar reductions as those treat... Continue reading Hope for Type 1 diabetes sufferers comes in the form of an artificial pancreas Sat, 22 Jun, 2013 08:40 AM PDT CHICAGO  - Type 1 diabetics, who run the risk of dangerously low blood sugar, may be a step closer to getting help from a crude artificial pancreas device that can read blood sugar levels and automatically turn off the flow of insulin after a clinical trial showed the device is safe. Continue reading

You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.